Results 161 to 170 of about 3,877 (197)
Renal vein thrombosis with inferior vena cava extension in PLA2R-positive membranous nephropathy: A radiological mimic of acute pyelonephritis. [PDF]
Nalla S, Patil PS, Maydari S, Swathi P.
europepmc +1 more source
Beyond Titers: Phospholipase A2 Receptor Epitope Complexity as a New Lens in Membranous Nephropathy. [PDF]
Al-Rabadi L, Avasare RS.
europepmc +1 more source
Efficacy and Safety of Moderate-Dose Glucocorticoids with Tacrolimus in High-Risk Membranous Nephropathy: A Real-World Comparison of Three Immunosuppressive Regimens. [PDF]
Sui L +9 more
europepmc +1 more source
The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
Anti-PLA2R antibodies (Ab) are a diagnostic and prognostic biomarker in primary membranous nephropathy (PMN). We assessed the relationship between the levels of anti-PLA2R Ab at diagnosis and different variables related to disease activity and prognosis ...
Boris Gilburd, Olga Lesya Kukuy
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Analyst, 2022
M-type phospholipase A2 receptor (PLA2R) is a significant biomarker contributing to the clinical diagnosis of idiopathic membranous nephropathy (IMN).
Xinxin Xu +7 more
openaire +2 more sources
M-type phospholipase A2 receptor (PLA2R) is a significant biomarker contributing to the clinical diagnosis of idiopathic membranous nephropathy (IMN).
Xinxin Xu +7 more
openaire +2 more sources
American Journal of Kidney Diseases, 2022
Phospholipase A2 receptor (PLA2R)-associated membranous nephropathy (MN) with circulating serum autoantibodies to PLA2R (SAb+) but no deposits of PLA2R antigen in glomerular tissue by immunofluorescence (GAg-) has been reported. However, little is known about the clinicopathological characteristics or prognosis of this subtype of MN.Retrospective ...
Fang Yang, Jiao Luo, Jianwei Tian
exaly +3 more sources
Phospholipase A2 receptor (PLA2R)-associated membranous nephropathy (MN) with circulating serum autoantibodies to PLA2R (SAb+) but no deposits of PLA2R antigen in glomerular tissue by immunofluorescence (GAg-) has been reported. However, little is known about the clinicopathological characteristics or prognosis of this subtype of MN.Retrospective ...
Fang Yang, Jiao Luo, Jianwei Tian
exaly +3 more sources
Clinical and Experimental Nephrology, 2023
Phospholipase A2 receptor (PLA2R)-associated membranous nephropathy (MN) was manifested as seropositive for PLA2R antibodies (SAb) and/or glomerular PLA2R antigens' (GAg) deposits. According to the test of SAb and GAg, PLA2R-associated MN can be divided into SAb + /GAg-, SAb-/GAg + , and SAb + /GAg + groups. The clinical characteristics and outcomes of
Ping Lan
exaly +3 more sources
Phospholipase A2 receptor (PLA2R)-associated membranous nephropathy (MN) was manifested as seropositive for PLA2R antibodies (SAb) and/or glomerular PLA2R antigens' (GAg) deposits. According to the test of SAb and GAg, PLA2R-associated MN can be divided into SAb + /GAg-, SAb-/GAg + , and SAb + /GAg + groups. The clinical characteristics and outcomes of
Ping Lan
exaly +3 more sources
American Journal of Nephrology
Introduction: PLA2R-associated primary membranous nephropathy (PMN) was classified as IgG4-associated autoimmune disease, in which anti-PLA2R antibody is predominantly IgG4 subclass. Our objective was to explore the capability of anti-PLA2R IgG4-to-IgG ratio for predicting remission in PLA2R-associated PMN patients.
Yuting Liu +8 more
openaire +2 more sources
Introduction: PLA2R-associated primary membranous nephropathy (PMN) was classified as IgG4-associated autoimmune disease, in which anti-PLA2R antibody is predominantly IgG4 subclass. Our objective was to explore the capability of anti-PLA2R IgG4-to-IgG ratio for predicting remission in PLA2R-associated PMN patients.
Yuting Liu +8 more
openaire +2 more sources
Nephron
Introduction: The utility of M-type phospholipase A2 receptor antibody (PLA2R-Ab) for risk stratification in membranous nephropathy (MN) remains suboptimal, while soluble T-cell immunoglobulin and mucin-domain containing-3 (sTim-3) has been confirmed as a critical immune regulator in kidney diseases. This study investigated the prognostic value of sTim-
Tianyu, Zheng +10 more
openaire +2 more sources
Introduction: The utility of M-type phospholipase A2 receptor antibody (PLA2R-Ab) for risk stratification in membranous nephropathy (MN) remains suboptimal, while soluble T-cell immunoglobulin and mucin-domain containing-3 (sTim-3) has been confirmed as a critical immune regulator in kidney diseases. This study investigated the prognostic value of sTim-
Tianyu, Zheng +10 more
openaire +2 more sources

